Non-Small Cell Lung Cancer Coverage from Every Angle
Advertisement
Advertisement

Nicolas Guibert, MD, PhD, on Non–Small Cell Lung Cancer: Clinical Implications of Using a New Algorithm to Predict Response to Immunotherapy

Posted: Tuesday, March 12, 2019

Nicolas Guibert, MD, PhD, of Toulouse University Hospital, talks about the possible future role of a new algorithm used to predict outcomes with immunotherapy in advanced non–small cell lung cancer.



By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.